
Nouveal
App for patients before and after surgery.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
* | N/A | Early VC | |
Total Funding | 000k |
EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 221 % | 44 % | 17 % | 416 % | (17 %) | 13 % | - |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | (90 %) | (129 %) | (106 %) | 29 % | 22 % | - | - |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (100 %) | (152 %) | (124 %) | 28 % | 17 % | - | - |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
Nouveal, established in 2013 by co-founders Guillaume Fayolle and Alexandre Falzon, operates as a key player in the digital health sector, specializing in remote patient monitoring and care pathway management. The company's trajectory includes a significant milestone on July 8, 2020, when La Poste Group became its majority shareholder, integrating Nouveal into its La Poste Santé & Autonomie subsidiary to bolster its presence in the home healthcare market. Subsequently, in January 2023, Nouveal merged with Maela, another firm in the medical remote monitoring space, to form a consolidated entity under the name MN Santé, further solidifying its market position. The founders, Fayolle and Falzon, stepped away from their operational roles in July 2023.
The company's core business involves commercializing a digital platform for healthcare providers that optimizes the medical follow-up of patients. This platform serves a client base that includes approximately 350 healthcare facilities and 5,000 city-based professionals, with notable partnerships with major players like AP-HP (Paris's public hospital system) and Ramsay Santé. Nouveal's business model is centered on providing software-as-a-service (SaaS) solutions to digitize and streamline the patient journey, from pre-admission to post-operative remote monitoring.
Nouveal's flagship product, initially known as e-fitback, is a comprehensive care management platform. It facilitates administrative pre-admission, prepares patients for hospitalization with educational content and checklists, and enables post-discharge follow-up through medical questionnaires that collect vital signs and recovery data. A key feature is an integrated instant messaging service for 24/7 communication between patients and medical staff. The platform has been adapted for various specialties, including Onco'nect for oncology, and was notably used to develop Covidom in partnership with AP-HP during the COVID-19 crisis, a remote surveillance application for infected patients that helped to alleviate hospital overcrowding.
Keywords: remote patient monitoring, care pathway management, digital health, medical telemonitoring, patient journey digitization, La Poste Santé, Maela, e-health solutions, post-operative follow-up, chronic disease management, e-fitback, Onco'nect, Covidom, healthcare SaaS, patient engagement platform, pre-admission software, medical data collection, healthcare communication, hospital-at-home, telemedicine services
Tech stack
Investments by Nouveal
Edit